Literature DB >> 12695445

Are we underestimating the full potential of early thrombolytic treatment in patients with acute myocardial infarction?

C J Terkelsen1, J F Lassen, B L Nørgaard, J C Gerdes, T T Nielsen, H R Andersen.   

Abstract

Use of the Boersma curve in order to describe the beneficial effect of thrombolytic treatment at different treatment delays seems questionable, because the curve may underestimate the favourable prognostic effects of early thrombolysis in patients with acute myocardial infarction

Entities:  

Mesh：

Year:  2003        PMID： 12695445      PMCID： PMC1767659          DOI： 10.1136/heart.89.5.483

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


  17 in total

1.  Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).

Authors:  R G Wilcox; G von der Lippe; C G Olsson; G Jensen; A M Skene; J R Hampton
Journal:  Lancet       Date:  1988-09-03       Impact factor: 79.321

2.  Improved survival after early thrombolysis in acute myocardial infarction. A randomised trial by the Interuniversity Cardiology Institute in The Netherlands.

Authors:  M L Simoons; P W Serruys; M vd Brand; F Bär; C de Zwaan; J Res; F W Verheugt; X H Krauss; W J Remme; F Vermeer
Journal:  Lancet       Date:  1985-09-14       Impact factor: 79.321

3.  Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1993-08-05       Impact factor: 91.245

4.  Randomised trial of late thrombolysis in patients with suspected acute myocardial infarction. EMERAS (Estudio Multicéntrico Estreptoquinasa Repúblicas de América del Sur) Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1993-09-25       Impact factor: 79.321

5.  Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction.

Authors: 
Journal:  Lancet       Date:  1993-09-25       Impact factor: 79.321

6.  An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.

Authors: 
Journal:  N Engl J Med       Date:  1993-09-02       Impact factor: 91.245

7.  A prospective placebo-controlled double-blind multicenter trial of intravenous streptokinase in acute myocardial infarction (ISAM): long-term mortality and morbidity.

Authors:  R Schröder; K L Neuhaus; A Leizorovicz; T Linderer; U Tebbe
Journal:  J Am Coll Cardiol       Date:  1987-01       Impact factor: 24.094

8.  Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction.

Authors:  F Van de Werf; A E Arnold
Journal:  BMJ       Date:  1988-11-26

9.  Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. AIMS Trial Study Group.

Authors: 
Journal:  Lancet       Date:  1988-03-12       Impact factor: 79.321

10.  Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1988-08-13       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.